A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology

Authors:

Abstract
No abstract available
Funding Information
  • Bristol-Myers Squibb Canada

This publication has 28 references indexed in Scilit: